IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

A recent study comparing external beam radiation therapy (EBRT) and cryoablation in patients with localized prostate cancer found that cryoablation was noninferior to EBRT in terms of disease ...

For this Wellness Wednesday, we spoke with Cruz about Cryo T-shock Therapy.

Clinicians should collect data on all patients undergoing focal cryoablation (including details of case selection, methods of follow-up and outcomes) for local audit. Clinicians should enter details ...

Richard Fine, United States Summary conclusion: The ICE3 trial suggests that cryoablation with ProSense®, complemented by adjuvant therapy, is a viable alternative to surgical excision for ...

About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous ...

About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, ...